Application of vertigo diagnosis and treatment system for benign paroxysmal positional vertigo in the elderly

doi:10.3877/cma.j.issn.2095-8757.2019.04.004

Abstract

Abstract:

Objective

To evaluate the efficacy of vertigo diagnosis and treatment system for benign paroxysmal positional vertigo (BPPV) in the elderly.

Methods

360 patients admitted from September 2018 to March 2019 in Zhejiang Hospital diagnosed as BPPV were included. There were 183 elder patients and 177 young patients. Among the elderly BPPV patients, 98 patients were treated with vertigo diagnosis and treatment system (group A) and 85 patients were treated with manual repositioning (group B).The young patients were treated with vertigo diagnosis and treatment system (group C). The reposition effects of the 3 groups were observed and compared, and the recurrences were followed up for 6 months. Analysis of variance was used for comparison of measurement data between groups, Kruskal-Wallis H test and chi-square test were used for comparison of count data.

Results

While using vertigo diagnosis and treatment system for reposition treatment, there was no statistically significant difference in the total first-time and second-time reposition effective rates between the elderly and the young and middle-aged patients with BPPV, as well as patients with different subtypes of BPPV (allP > 0.05). Compared with the elderly BPPV patients with manual treatment, the total first-time reposition effective rates of elderly patients with vertigo diagnosis and treatment system and the first-time reposition effective rates of pc-BPPV subtype were significantly higher, and the differences were statistically significant (χ²=4.352、5.694, allP< 0.05). There was no significant difference between the total sencond-time reposition effective rates and the first-time and sencond-time reposition effective rates of hc-BPPV, hc-BPPV-cu subtypes (allP > 0.05). After 6 months of follow-up, there were no significant differences in the reposition effective rates among group A and groups B, group C (χ²=1.225, 1.262,P> 0.05); and there was no significant differences in the reposition effective rates of BPPV patients in each subtype of groups A and B (χ²=1.286, 0.019, 0.014,P> 0.05).

Conclusion

Vertigo diagnosis and treatment system has good short-term curative effect and stable long-term curative effect for elder BBPV patients. It has a high probability of success, and is safe and easy to perform.

Key words: Benign paroxysmal positional vertigo, Dix-Hallpike test, Roll test, Vertigo diagnosis and treatment system

Yue Lou, Liangguo Xu, Miao Cai, Yanwen Wang, Siran Zhang, Xiaoli Liu. Application of vertigo diagnosis and treatment system for benign paroxysmal positional vertigo in the elderly[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2019, 06(04): 18-22.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlnbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8757.2019.04.004

https://zhlnbyjdzzz.cma-cmc.com.cn/EN/Y2019/V06/I04/18

Figures/Tables 4

References 20

[1]	Kim JS, Zee DS. Clinical practice. Benign paroxysmal positional vertigo[J]. N Engl J Med, 2014, 370(12):1138-1147.
[2]	Balatsouras DG, Koukoutsis G, Fassolis A, et al.Benign paroxysmal positional vertigo in the elderly: current insights[J].Clin Interv Aging, 2018, 13:2251-2266.
[3]	Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population[J]. Neurology, 2005, 65(6):898-904.
[4]	Parnes LS, Agrawal SK, Atlas J. Diagnosis and management of benign paroxysmalpositional vertigo (BPPV) [J]. CMAJ, 2003, 169(7):681-693.
[5]	Kollén L, Frändin K, Möller M, et al. Benign paroxysmal positional vertigo is a common cause of dizziness and unsteadiness in a large population of 75-year-olds[J]. Aging Clin Exp Res, 2012, 24(4):317-323.
[6]	Shan X, Peng X, Wang E. Efficacy of computer-controlled repositioning procedure for benign paroxysmal positional vertigo[J]. Laryngoscope, 2015, 125(3):715-719.
[7]	Bertholon P, Brandt T, Fife T, et al. Benign paroxysmal positional vertigo: Diagnostic criteria[J]. J Vestib Res, 2015, 25(3-4):105-117.
[8]	Bhattacharyya N, Gubbels SP, Schwartzet SR, al. Clinical practice guideline : benign paroxysmal positional vertigo (Update) executive summary[J]. Otolaryngol Head Neck Surg, 2017, 156(3):403-416.
[9]	Luryi AL, Lawrence J, Bojrab DI, et al. Recurrence in benign paroxysmal positional vertigo: A large, single-institution study[J]. Otol Neurotol, 2018, 39(5):622-627.
[10]	van Duijn JG, Isfordink LM, Nij Bijvank JA, et al. Head and neck surgery rapid systematic review of the epley maneuver for treating posterior canal Benign Paroxysmal Positional Vertigo[J].Otolaryngol Head Neck Surg, 2014, 150(6):925-932.
[11]	Furman JM, Raz Y, Whitney SL. Geriatric vestibulopathy assessment and management[J]. Curr Opin Otolaryngol Head Neck Surg, 2010, 18(5):386-391.
[12]	Ribeiro KM, Freitas RV, Ferreira LM. Effects of balance Vestibular Rehabilitation Therapy in elderly with Benign Paroxysmal Positional Vertigo: a randomized controlled trial[J]. Disabil Rehabil, 2017, 39(12):1198-1206.
[13]	柳冰，谭训莲，熊欣平.手法复位与药物联合治疗老年BPPV的疗效观察[J].江西医药，2016，51(11)：1259-1261.
[14]	Maas BDPJ, Bruintjes TD, van der Zaag-Loonen HJ, et al. Physical and Emotional Burden of the Epley Maneuver in the elderly[J]. Otol Neurotol, 2019, 40(8):1082-1087.
[15]	Liu X, Yan Y, Li X, et al. Automated mechanical repositioning treatment for posterior canal Benign Paroxysmal Positional Vertigo : A single-center experience and literature review[J]. Eur Neurol, 2017, 78(5-6):240-246.
[16]	Song CI, Kang BC, Yoo MH, et al. Management of 210 patients with benign paroxysmal positional vertigo: AMC protocol and outcomes[J]. Acta Otolaryngol, 2015, 135(5):422-428.
[17]	Amor-dorado JC, Barreira-ferna MP, Aran-gonzalez I, et al. Particle repositioning maneuver versus brandt-daroff exercise for treatment of unilateral idiopathic bppv of the posterior semicircular canal : A randomized prospective clinical trial with short-and long-term outcome[J]. Otol Neurotol, 2012, 33(8):1401-1407.
[18]	Dispenza F, Mazzucco W, Mazzola S, et al. Observational study on risk factors determining residual dizziness after successful benign paroxysmal positional vertigo treatment: The role of subclinical BPPV[J]. Acta Otorhinolaryngol Ital, 2019, 39(5):347-352.
[19]	Zhu CT, Zhao XQ, Ju Y, et al. Clinical characteristics and risk factors for the recurrence of Benign Paroxysmal Positional Vertigo[J]. Front Neurol, 2019, 10:1190.
[20]	Kao CL, Hsieh WL, Chern CM, et al. Clinical features of Benign Paroxysmal Positional Vertigo (BPPV) in Taiwan: differences between young and senior age groups[J]. Arch Gerontol Geriatr, 2009, 49 Suppl 2:S50-54.

组别	例数	年龄（岁）	性别（男/女，例）	患病侧（左/右，例）	发病类型（pc-BPPV/ hc-BPPV/ hc-BPPV-cu，例）
组别	例数	年龄（岁）	性别（男/女，例）	患病侧（左/右，例）	A组	98	60～87（69±7）	41/57	40/58	74/16/8
B组	85	61～84（67±6）	36/49	41/44	59/18/8
C组	177	23～59（44±10）	62/115	85/92	119/30/28
检验值	?	F=36.250	χ²=1.248	χ²=2.546	χ²=3.455
P值	?	<0.05	>0.05	>0.05	>0.05

组别	例数	年龄（岁）	性别（男/女，例）	患病侧（左/右，例）	发病类型（pc-BPPV/ hc-BPPV/ hc-BPPV-cu，例）
组别	例数	年龄（岁）	性别（男/女，例）	患病侧（左/右，例）	A组	98	60～87（69±7）	41/57	40/58	74/16/8
B组	85	61～84（67±6）	36/49	41/44	59/18/8
C组	177	23～59（44±10）	62/115	85/92	119/30/28
检验值	?	F=36.250	χ²=1.248	χ²=2.546	χ²=3.455
P值	?	<0.05	>0.05	>0.05	>0.05

组别	例数	一次复位	二次复位	pc-BPPV		hc-BPPV		hc-BPPV-cu
组别	例数	一次复位	二次复位	一次复位	二次复位	一次复位	二次复位	一次复位	二次复位
A组	98	75（76.5）	84（85.7）	63（85.1）	68（91.9）	11（68.8）	14（87.5）	1（12.5）	4（14.3）
C组	177	131（74.0）	145（81.9）	103（86.6）	111（93.3）	24（80.0）	27（90.0）	2（25.0）	7（25.0）
χ²值	?	0.226	0.231	0.076	0.130	0.726	0.067	0.605	2.057
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	一次复位	二次复位	pc-BPPV		hc-BPPV		hc-BPPV-cu
组别	例数	一次复位	二次复位	一次复位	二次复位	一次复位	二次复位	一次复位	二次复位
A组	98	75（76.5）	84（85.7）	63（85.1）	68（91.9）	11（68.8）	14（87.5）	1（12.5）	4（14.3）
C组	177	131（74.0）	145（81.9）	103（86.6）	111（93.3）	24（80.0）	27（90.0）	2（25.0）	7（25.0）
χ²值	?	0.226	0.231	0.076	0.130	0.726	0.067	0.605	2.057
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	一次复位	二次复位	pc-BPPV		hc-BPPV		hc-BPPV-cu
组别	例数	一次复位	二次复位	一次复位	二次复位	一次复位	二次复位	一次复位	二次复位
A组	98	75（76.5）	84（85.7）	63（85.1）	68（91.9）	11（68.8）	14（87.5）	1（12.5）	4（14.3）
B组	85	53（62.4）	67（78.8）	40（67.8）	51（86.4）	13（72.2）	15（83.3）	0（0.0）	1（12.5）
χ²值	?	4.352	1.498	5.694	1.036	0.049	0.117	1.067	0.410
P值	?	<0.05	>0.05	<0.05	>0.05	>0.05	>0.05	>0.05	>0.05

Please choose a citation manager

Content to export